MMWR Weekly: Current Volume (73)
April 25, 2024 / No. 16
- Use of Ebola Vaccines — Worldwide, 2021–2023
- SARS-CoV-2 Viral Shedding and Rapid Antigen Test Performance — Respiratory Virus Transmission Network, November 2022–May 2023
- Investigation of Presumptive HIV Transmission Associated with Receipt of Platelet-Rich Plasma Microneedling Facials at a Spa Among Former Spa Clients — New Mexico, 2018–2023
- Use of an Additional Updated 2023–2024 COVID-19 Vaccine Dose for Adults Aged ≥65 Years: Recommendations of the Advisory Committee on Immunization Practices — United States, 2024
- Notes from the Field: Group A Streptococcus Bacteremia in Persons Who Inject Drugs — Northern Vermont, January 2020–October 2023
- QuickStats: Percentage of Employed Adults Aged ≥18 Years Who Slept <7 Hours per 24-Hour Period, by Sex and Number of Working Hours per Week — United States, 2022
April 18, 2024 / No. 15
- Heat-Related Emergency Department Visits — United States, May–September 2023
- Durability of Original Monovalent mRNA Vaccine Effectiveness Against COVID-19 Omicron–Associated Hospitalization in Children and
Adolescents — United States, 2021–2023 - COVID-19 Vaccination Coverage, and Rates of SARS-CoV-2 Infection and COVID-19–Associated Hospitalization Among Residents in Nursing Homes — National Healthcare Safety Network, United States, October 2023–February 2024
- Use of the Pfizer Pentavalent Meningococcal Vaccine Among Persons Aged ≥10 Years: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023
- Vital Signs: Mammography Use and Association with Social Determinants of Health and Health-Related Social Needs Among Women — United States, 2022
- QuickStats: Percentage of Children and Adolescents Aged 3–17 Years Who Ever Received a Diagnosis of Autism Spectrum Disorder, by Family Income, 2020–2022
April 11, 2024 / No. 14
- Measles — United States, January 1, 2020–March 28, 2024
- State Medicaid Coverage for Tobacco Cessation Treatments and Barriers to Accessing Treatments — United States, 2018–2022
- COVID-19 Vaccination Coverage — World Health Organization African Region, 2021–2023
- Infections Associated with Medtronic Duet External Ventricular Drains — Rhode Island Hospital, Providence, Rhode Island, January 2023–January 2024
- Assessment of Risk for Sudden Cardiac Death Among Adolescents and Young Adults After Receipt of COVID-19 Vaccine — Oregon, June 2021–December 2022
- Notes from the Field: Neonatal Salmonellosis Associated with Backyard Poultry — Oregon, November 2023
April 4, 2024 / No. 13
- Surveillance To Track Progress Toward Polio Eradication — Worldwide, 2022–2023
- Federal Retail Pharmacy Program Contributions to Bivalent mRNA COVID-19 Vaccinations Across Sociodemographic Characteristics — United States, September 1, 2022–September 30, 2023
- Notice to Readers: Change in Publication Date of QuickStats
- Erratum: Vol. 71, No. 19
- QuickStats: Life Expectancy at Birth, by Sex — United States, 2019–2022
- Birth Prevalence of Sickle Cell Disease and County-Level Social Vulnerability — Sickle Cell Data Collection Program, 11 States, 2016–2020
- Ceftriaxone-Resistant Gonorrhea — China, 2022
- Implications of Measles Inclusion by Commercial Syndromic Polymerase Chain Reaction Panels — United States, May 2022–April 2023
- Tuberculosis — United States, 2023
- Interim Effectiveness of Updated 2023–2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19–Associated Hospitalization Among Adults Aged ≥18 Years with Immunocompromising Conditions — VISION Network, September 2023–February 2024
March 21, 2024 / No. 11
- Tuberculosis Preventive Treatment Update — U.S. President’s Emergency Plan for AIDS Relief, 36 Countries, 2016–2023
- Surveillance for Coccidioidomycosis, Histoplasmosis, and Blastomycosis During the COVID-19 Pandemic — United States, 2019–2021
- Notes from the Field: Expanded Laboratory Testing for Varicella — Minnesota, 2016–2023
March 14, 2024 / No. 10
- Outbreak Linked to Morel Mushroom Exposure — Montana, 2023
- Notes from the Field: Surveillance for Multisystem Inflammatory Syndrome in Children — United States, 2023
- Notes from the Field: Measles Outbreak — Cook County, Illinois, October–November 2023
- Erratum: Vol. 72, No. 36
March 7, 2024 / No. 9
- Prevalence of Self-Reported Hypertension and Antihypertensive Medication Use Among Adults — United States, 2017–2021
- Years of Potential Life Lost and Mean Age of Adults Experiencing Nontraumatic, Out-of-Hospital Cardiac Arrests — Chicago, 2014–2021
- Racial and Ethnic Differences in Social Determinants of Health and Health- Related Social Needs Among Adults — Behavioral Risk Factor Surveillance System, United States, 2022
- Early Estimate of Nirsevimab Effectiveness for Prevention of Respiratory Syncytial Virus–Associated Hospitalization Among Infants Entering Their First Respiratory Syncytial Virus Season — New Vaccine Surveillance Network, October 2023–February 2024
- Notes from the Field: Emergency Department Visits for Unsupervised Pediatric Melatonin Ingestion — United States, 2019–2022
- Deaths from Excessive Alcohol Use — United States, 2016–2021
- Progress Toward Rubella and Congenital Rubella Syndrome Elimination — Worldwide, 2012–2022
- Interim Estimates of 2023–24 Seasonal Influenza Vaccine Effectiveness — United States
- Interim Influenza Vaccine Effectiveness Against Laboratory-Confirmed Influenza — California, October 2023–January 2024
- Interim Effectiveness of Updated 2023–2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalization Among Immunocompetent Adults Aged ≥18 Years — VISION and IVY Networks, September 2023–January 2024
- QuickStats: Percentage of Children and Adolescents Aged 5–17 Years Who Had Chronic School Absenteeism Due to Illness, Injury, or Disability During the Past 12 Months, by Age Group and Year — National Health Interview Survey, United States, 2019 and 2022
February 22, 2024 / No. 7
- Progress Toward Measles Elimination — World Health Organization Eastern Mediterranean Region, 2019–2022
- Outbreak of Mycobacterium orygis in a Shipment of Cynomolgus Macaques Imported from Southeast Asia — United States, February–May 2023
- Notes from the Field: Reemergence of Mycoplasma pneumoniae Infections in Children and Adolescents After the COVID-19 Pandemic, United States, 2018–2024
- QuickStats: Percentage of Adults Aged ≥18 Years Who Lacked Reliable Transportation for Daily Living in the Past 12 Months, by Disability Status and Age Group — National Health Interview Survey, United States, 2022
February 15, 2024 / No. 6
- Surveillance for Lyme Disease After Implementation of a Revised Case Definition — United States, 2022
- Routes of Drug Use Among Drug Overdose Deaths — United States, 2020–2022
- Hepatitis A Exposure Response and Outbreak Prevention in a Large Urban Jail — Los Angeles County, California, May–July 2023
- Notes from the Field: Long COVID Prevalence Among Adults — United States, 2022
- QuickStats: Percentage of Adults Aged ≥18 Years Who Were Advised During the Past 12 Months by a Doctor or Other Health Professional to Increase Their Amount of Physical Activity or Exercise, by Age Group and Sex — National Health Interview Survey, United States, 2022
February 8, 2024 / No. 5
- Characteristics of Alcohol, Marijuana, and Other Drug Use Among Persons Aged 13–18 Years Being Assessed for Substance Use Disorder Treatment — United States, 2014–2022
- Selection of Antibiotics as Prophylaxis for Close Contacts of Patients with Meningococcal Disease in Areas with Ciprofloxacin Resistance — United States, 2024
- Severe Work-Related Injuries in the Oil and Gas Extraction Industry — 32 Federal Occupational Safety and Health Administration Jurisdictions, United States, January 2015–July 2022
- Comparison of Administration of 8-Milligram and 4-Milligram Intranasal Naloxone by Law Enforcement During Response to Suspected Opioid Overdose — New York, March 2022–August 2023
- Notes from the Field: Rapidly Linking an Outbreak of Salmonella Typhimurium Infections to Domestically Grown Cantaloupes Through Early Collaboration — United States, 2022
- QuickStats: Percentage of Children and Adolescents Aged 5–17 Years Who Had Ever Received a Diagnosis of Attention-Deficit/Hyperactivity Disorder, by Urbanization Level and Age Group — National Health Interview Survey, United States, 2020–2022
February 1, 2024 / No. 4
- Surveillance for Acute Flaccid Myelitis ― United States, 2018–2022
- Early Estimates of Updated 2023–2024 (Monovalent XBB.1.5) COVID-19 Vaccine Effectiveness Against Symptomatic SARS-CoV-2 Infection Attributable to Co-Circulating Omicron Variants Among Immunocompetent Adults — Increasing Community Access to Testing Program, United States, September 2023–January 2024
- Notes from the Field: Severe Vibrio vulnificus Infections During Heat Waves — Three Eastern U.S. States, July–August 2023
- Notes from the Field: Dengue Outbreak — Peru, 2023
Read this report en Español - Notes from the Field: Cluster of Severe Illness from Neptune’s Fix Tianeptine Linked to Synthetic Cannabinoids — New Jersey, June–November 2023
- QuickStats: Percentage of Newborns Breastfed Between Birth and Discharge from Hospital, by Maternal Age — National Vital Statistics System, 49 States and the District of Columbia, 2021 and 2022
- Prevalence of Cardiometabolic Diseases Among Racial and Ethnic Subgroups in Adults — Behavioral Risk Factor Surveillance System, United States, 2013–2021
- Underuse of Antiviral Drugs to Prevent Progression to Severe COVID-19 — Veterans Health Administration, March–September 2022
- Deaths of U.S. Citizens Undergoing Cosmetic Surgery — Dominican Republic, 2009–2022
- Notes from the Field: Nontuberculous Mycobacteria Infections After Cosmetic Surgery Procedures in Florida — Nine States, 2022–2023
- QuickStats: Percentage of Children and Adolescents Aged ≤17 Years Who Visited an Urgent Care Center or a Clinic in a Drug Store or Grocery Store in the Past 12 Months, by Age Group and Year — National Health Interview Survey, United States, 2021–2022
January 18, 2024 / No. 2
- Cannabis Use Among Students in Grades 8, 10, and 12, by Sex — King County, Washington, 2008–2021
- Pseudomonas Infection Outbreak Associated with a Hotel Swimming Pool — Maine, March 2023
- Detecting Mpox Cases Through Wastewater Surveillance — United States, August 2022–May 2023
- Mpox Outbreak — Los Angeles County, California, May 4–August 17, 2023
- QuickStats: Percentage of Adults Aged ≥18 Years with Diagnosed Diabetes, by Urbanization Level and Age Group — National Health Interview Survey, United States, 2022
January 11, 2024 / No. 1
- Topical Antifungal Prescribing for Medicare Part D Beneficiaries — United States, 2021
- Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger — United States, 2024
- Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2024
- Effectiveness of Bivalent mRNA COVID-19 Vaccines in Preventing COVID-19–Related Thromboembolic Events Among Medicare Enrollees Aged ≥65 Years and Those with End Stage Renal Disease — United States, September 2022–March 2023
- Notice to Readers: Change in Publication Date of MMWR Series
- QuickStats: Percentage of Children and Adolescents Aged 5–17 Years Who Had Been the Victim of Violence or Witnessed Violence in Their Neighborhood, by Disability Status and Age Group — National Health Interview Survey, United States, 2022